Abstract
Purpose
Materials and Methods
Results
Conclusion
ACKNOWLEDGEMENTS
Notes
AUTHOR CONTRIBUTIONS:
Conceptualization: S Bae, H Kwon.
Data curation: S Bae.
Formal analysis: S Bae.
Funding acquisition: H Kwon.
Investigation: S Bae, H Kwon.
Methodology: S Bae, H Kwon.
Project administration: H Kwon.
Resources: S Bae, H Kwon.
Software: S Bae, H Kwon.
Supervision: H Kwon.
Validation: S Bae, H Kwon.
Visualization: S Bae, H Kwon.
Writing—original draft: S Bae, H Kwon.
Writing—review & editing: S Bae, H Kwon.
References
Table 1
No. | Author (year) | Study design | Study period | Location | Outcome | Pollutant | Unit | Effect size |
---|---|---|---|---|---|---|---|---|
1 | Lee, et al. (1999)10 | Time series | 1991–1995 | Seoul | Non-accidental | SO2 | 50 ppb | RR 1.078 (1.057, 1.099) |
Ulsan | Non-accidental | SO2 | 50 ppb | RR 1.051 (0.991, 1.115) | ||||
Seoul | Non-accidental | TSP | 100 μg/m3 | RR 1.051 (1.031, 1.072) | ||||
Ulsan | Non-accidental | TSP | 100 μg/m3 | RR 0.999 (0.961, 1.039) | ||||
Seoul | Non-accidental | 1 hr max O3 | 50 bbp | RR 1.015 (1.005, 1.025) | ||||
Ulsan | Non-accidental | 1 hr max O3 | 50 bbp | RR 1.020 (0.889, 1.170) | ||||
2 | Hong, et al. (1999)13 | Time series | 1995 | Incheon | Total | TSP | 10 μg/m3 | 1.2% (0.2, 2.2) |
Total | PM10 | 10 μg/m3 | 1.2% (0.2, 2.1) | |||||
3 | Lee, et al. (1999)12 | Case-crossover | Seoul | Non-accidental | SO2 | 50 ppb | RR 1.023 (1.016, 1.084) | |
Non-accidental | Maximum O3 | 50 ppb | RR 1.023 (0.999, 1.048) | |||||
Non-accidental | TSP | 100 μg/m3 | RR 1.010 (0.988, 1.032) | |||||
4 | Hong, et al. (1999)11 | Time series | 1995–1996 | Incheon | Total | PM10 | 10 μg/m3 | RR 1.007 (1.001, 1.0013) |
Total | NO2 | RR 1.0026 (1.0006, 1.0046) | ||||||
Total | SO2 | RR 1.0023 (0.9996, 1.0051) | ||||||
Total | CO | RR 1.0019 (0.9990, 1.0049) | ||||||
Total | O3 | RR 0.9951 (0.9908, 0.9994) | ||||||
5 | Lee, et al. (2000)59 | Time series | 1991–1997 | 7 cities | Total | TSP | 100 μg/m3 | 0.5–4% |
Total | SO2 | 50 ppb | RR 1.03 (1.01, 1.05) | |||||
6 | Kwon, et al. (2001)20 | Time series | 1994–1998 | Seoul | Total | PM10 | IQR (42.1 μg/m3) | OR 1.014 (1.006, 1.022) |
Total | CO | IQR (0.59 ppm) | OR 1.022 (1.017, 1.029) | |||||
Total | NO2 | IQR (14.6 ppb | ||||||
Total | SO2 | IQR (9.9 ppb) | OR 1.020 (1.012, 1.028) | |||||
Total | O3 | IQR (20.5 ppb) | OR 1.010 (1.002, 1.017) | |||||
7 | Hong, et al. (2002)60 | Time series | 1995–1998 | Seoul | Stroke | PM10 | IQR | 1.5% (1.3, 1.8) |
Stroke | O3 | IQR | 2.9% (0.3, 5.5) | |||||
Stroke | NO2 | IQR | 3.1% (1.1, 5.1) | |||||
Stroke | SO2 | IQR | 2.9% (0.8, 5.0) | |||||
Stroke | CO | IQR | 4.1% (1.1, 7.2) | |||||
8 | Hong, et al. (2002)21 | Time series | 1991–1997 | Seoul | Ischemic stroke | TSP | IQR | RR 1.03 (1.00, 1.06) |
Ischemic stroke | SO2 | RR 1.04 (1.01, 1.08) | ||||||
Ischemic stroke | NO2 | IQR | RR 1.04 (1.01, 1.07) | |||||
Ischemic stroke | CO | IQR | RR 1.06 (1.02, 1.09) | |||||
Ischemic stroke | O3 | IQR | RR 1.06 (1.02, 1.10) | |||||
9 | Ha, et al. (2003)61 | Cohort | Total (postneonates) | PM10 | IQR (42.9 μg/m3) | RR 1.142 (1.096, 1.190) | ||
Respiratory (postneonates) | PM10 | IQR (42.9 μg/m3) | RR 2.018 (1.784, 2.283) | |||||
10 | Kim, et al. (2003)15 | Time series | 1995–1999 | Seoul | Non-accidental | PM10 | IQR (43.12 μg/m3) | 3.7% (2.1, 5.4) |
Respiratory | PM10 | IQR (43.12 μg/m3) | 13.9% (6.8, 21.5) | |||||
Cardiovascular | PM10 | IQR (43.12 μg/m3) | 4.4% (-1.0, 9.0) | |||||
Cerebrovascular | PM10 | IQR (43.12 μg/m3) | 6.3% (2.3, 10.5) | |||||
11 | Kim, et al. (2004)62 | Time series | 1997–2004 | Seoul | Non-accidental | PM10 (mean) | IQR (42.11 μg/m3) | RR 1.021 (1.009, 1.035) |
Non-accidental | PM10 (SD) | IQR (11.93 μg/m3) | RR 1.025 (1.000, 1.028) | |||||
12 | Lee, et al. (2007)63 | Time series | 2000–2004 | Seoul | Non-accidental | Asian dust event | Larger effect sizes in the model without Asian dust event | |
13 | Cho, et al. (2008)64 | Time series | 2001 | Seoul | Respiratory | Fine particle count | IQR (10.221 number/cm3) | 5.73% (5.03, 6.45) |
Respiratory | Respiratory particle count | IQR (10.38 number/cm3) | 5.82% (5.13, 6.53) | |||||
14 | Son, et al. (2008)22 | Case-crossover | 1999–2003 | Seoul | Infant | PM10 | 1 μg/m3 | OR 1.000 (0.998, 1.002) |
Infant | NO2 | 1 unit | OR 1.002 (0.994, 1.009) | |||||
Infant | SO2 | 1 unit | OR 1.015 (0.973, 1.058) | |||||
Infant | CO | 1 unit | OR 1.029 (0.833, 1.271) | |||||
Infant | O3 | 1 unit | OR 0.984 (0.977, 0.992) | |||||
15 | Yi, et al. (2010)75 | Case-crossover | 2000–2006 | Seoul | Non-accidental | PM10 | 10 μg/m3 | 0.28% (0.12, 0.44) |
Cardiovascular | PM10 | 10 μg/m3 | 0.51% (0.19, 0.83) | |||||
Respiratory | PM10 | 10 μg/m3 | 0.59% (-0.08, 1.26) | |||||
16 | Kim, et al. (2010)19 | Case-crossover | 2004 | 7 cities | Suicide | PM10 | IQR | 9.0% (2.4, 16.1) |
Suicide | PM2.5 | IQR | 10.1% (2.0, 19.0) | |||||
17 | Park, et al. (2011)65 | Time-series | 1999–2007 | Seoul | Non-accidental (high temp. ≥26.2℃) | SO2 | 0.5 ppb | 0.83% (0.42, 1.25) |
Non-accidental (low temp. <26.2℃) | SO2 | 0.5 ppb | 0.21% (0.07, 0.36) | |||||
18 | Son, et al. (2011)66 | Birth cohort | 2004–2007 | Seoul | All-cause infant | TSP | IQR | HR 1.44 (1.06, 1.97) |
All-cause infant | PM10 | IQR | HR 1.65 (1.18, 2.31) | |||||
All-cause infant | PM2.5 | IQR | HR 1.53 (1.22, 1.90) | |||||
All-cause infant | PM10-2.5 | IQR | HR 1.19 (0.83, 1.70) | |||||
Respiratory infant | TSP | IQR | HR 3.78 (1.18, 12.13) | |||||
Respiratory infant | PM10 | IQR | HR 6.20 (1.50, 25.66) | |||||
Respiratory infant | PM2.5 | IQR | HR 3.15 (1.26, 7.85) | |||||
Respiratory infant | PM10-2.5 | IQR | HR 2.86 (0.76, 10.85) | |||||
19 | Son, et al. (2012)14 | Case-crossover | 2000–2007 | Seoul | Total | PM10 | IQR | 0.94% (0.25, 1.62) |
Total | NO2 | IQR | 2.27% (1.03, 3.53) | |||||
Total | SO2 | IQR | 1.94% (0.80, 3.09) | |||||
Total | CO | IQR | 2.21% (1.00, 3.43) | |||||
Total | O3 | IQR | Positive/NS | |||||
Cardiovascular | PM10 | IQR | 1.95% (0.64, 3.27) | |||||
Cardiovascular | NO2 | IQR | 4.82% (2.18, 7.54) | |||||
Cardiovascular | SO2 | IQR | 3.64% (1.46, 5.87) | |||||
Cardiovascular | CO | IQR | 4.32% (1.77, 6.92) | |||||
Cardiovascular | O3 | IQR | Positive/NS | |||||
20 | Heo, et al. (2014)67 | Time-series | 2003–2007 | Seoul | Non-accidental, cardiovascular, respiratory | PM2.5 and components | Percentage of excess risk by PM3.5 and components | |
21 | Lim, et al. (2014)68 | GWR | 2008–2010 | Seoul | Cardiovascular | PM10 | Mean β (SE) 0.956 (0.102) | |
22 | Ha, et al. (2015)69 | Case-crossover | 2002–2008 | 7 citie | Unintentional injury | PM10 | IQR (48.3 μg/m3) | NS |
Unintentional injury | SO2 | IQR (0.005 ppm) | OR 1.119 (1.022, 1.226) | |||||
Unintentional injury | NO2 | IQR (0.02 ppm) | OR 1.208 (1.043, 1.400) | |||||
Unintentional injury | O3 | IQR (0.03 ppm) | NS | |||||
Unintentional injury | CO | IQR (0.36 ppm) | OR 1.012 (1.000, 1.024) | |||||
23 | Kim, et al. (2017)16 | Time-series | 1993–2009 | 7 cities | Non-accidental | PM10 | 10 μg/m3 | 0.51% (0.01, 1.01) |
24 | Kim, et al. (2018)70 | Time-series | 1993–2009 | 7 cities | Non-accidental | PM10 | Daily concentrations of ≥75 μg/m3 | 0.48% (0.30, 0.60) |
Cardiovascular | PM10 | Daily concentrations of ≥75 μg/m3 | 0.48% (0.14, 0.82) | |||||
Respiratory | PM10 | Daily concentrations of ≥75 μg/m3 | 1.13% (0.37, 1.89) | |||||
25 | Kim, et al. (2017)18 | Cohort | 2007–2013 | Seoul | Composite cardiovascular events | PM2.5 | 1 μg/m3 | HR 1.41 (1.32, 1.50) |
All-cause | PM2.5 | 1 μg/m3 | HR 1.32 (1.22, 1.43) | |||||
Cardiovascular | PM2.5 | 1 μg/m3 | HR 1.36 (1.11, 1.66) | |||||
Composite cardiovascular events | CO | IQR (0.25 ppm) | HR 1.79 (1.61, 1.99) | |||||
All-cause | CO | IQR (0.25 ppm) | HR 1.72 (1.52, 1.94) | |||||
Cardiovascular | CO | IQR (0.25 ppm) | HR 2.96 (2.12, 4.14) | |||||
Composite cardiovascular events | SO2 | IQR (2.54 ppb) | HR 1.94 (1.78, 2.11) | |||||
All-cause | SO2 | IQR (2.54 ppb) | HR 1.73 (1.55, 1.92) | |||||
Cardiovascular | SO2 | IQR (2.54 ppb) | HR 1.50 (1.14, 1.96) | |||||
Composite cardiovascular events | NO2 | IQR (18.4 ppb) | HR 2.30 (2.08, 2.55) | |||||
All-cause | NO2 | IQR (18.4 ppb) | HR 1.79 (1.59, 2.03) | |||||
Cardiovascular | NO2 | IQR (18.4 ppb) | HR 2.67 (1.94, 3.69) | |||||
Composite cardiovascular events | O3 | IQR (15.9 ppb) | HR 0.63 (0.63, 0.73) | |||||
All-cause | O3 | IQR (15.9 ppb) | HR 0.68 (0.63, 0.73) | |||||
Cardiovascular | O3 | IQR (15.9 ppb) | HR 0.59 (0.49, 0.71) | |||||
26 | Kim, et al. (2017)17 | Cohort | 2002–2014 | Korea | Non-accidental | PM10 | 10 μg/m3 | HR 1.05 (0.99, 1.11) |
Cardiovascular | PM10 | 10 μg/m3 | HR 1.02 (0.90,1.16) | |||||
Cerebrovascular | PM10 | 10 μg/m3 | HR 1.14 (0.93, 1.39) | |||||
Respiratory | PM10 | 10 μg/m3 | HR 1.19 (0.91, 1.57) | |||||
Cancer | PM10 | 10 μg/m3 | HR 1.02 (0.95, 1.10) | |||||
Lung cancer | PM10 | 10 μg/m3 | HR 0.96 (0.82,1.13) | |||||
27 | Lee, et al. (2018)71 | Case-crossover | 2002–2013 | 26 cities | Suicide | PM10 | IQR | Increased OR 1.2% (0.2, 2.3) |
NO2 | IQR | Increased OR 4.3% (1.9, 6.7) | ||||||
SO2 | IQR | Increased OR 2.2% (0.7, 3.8) | ||||||
CO | IQR | Increased OR 2.4% (0.9, 3.8) | ||||||
O3 | IQR | Increased OR 1.5% (-0.3, 3.2) |
Table 2
No. | Author (year) | Study design | Study period | Location | Outcome | Pollutant | Unit | Effect size |
---|---|---|---|---|---|---|---|---|
1 | Lee, et al. (2002)23 | Time series | Seoul | Asthma hospitalization | PM10 | IQR (40.4 µg/m3) | RR 1.07 (1.04, 1.11) | |
Asthma hospitalization | SO2 | IQR (4.4 ppb) | RR 1.11 (1.06, 1.17) | |||||
Asthma hospitalization | NO2 | IQR (14.6 ppb) | RR 1.15 (1.10, 1.20) | |||||
Asthma hospitalization | O3 | IQR (21.7 ppb) | RR 1.12 (1.07, 1.16) | |||||
Asthma hospitalization | CO | IQR (1.0 ppm) | RR 1.16 (1.10, 1.22) | |||||
2 | Lee, et al. (2005)24 | Panel study | 2003 | Seoul | Upper respiratory symptoms | NO2 | OR 1.12 (1.01, 1.24) | |
Lower respiratory symptoms | NO2 | OR 1.18 (1.06, 1.31) | ||||||
Lower respiratory symptoms | SO2 | OR 1.12 (1.01, 1.25) | ||||||
Lower respiratory symptoms | CO | OR 1.16 (1.02, 1.32) | ||||||
3 | Son, et al. (2006)25 | Time series | 2002 | Seoul | Asthma hospitalization (highest SES) | O3 | RR 1.12 (1.00, 1.25) | |
Asthma hospitalization (moderate SES) | O3 | RR 1.24 (1.08, 1.43) | ||||||
Asthma hospitalization (lowest SES) | O3 | RR 1.32 (1.11, 1.58) | ||||||
4 | Lee, et al. (2007)72 | Natural experiment | 2002 | Busan | Childhood asthma hospitalization | RR post Asian game period/RR baseline | 0.73 (0.49, 1.11) | |
5 | Lee, et al. (2006)73 | Time series | 2002 | Seoul | Asthma hospitalization | PM10 | IQR | 31% (14, 51) |
Asthma hospitalization | SO2 | IQR | 29% (8, 53) | |||||
Asthma hospitalization | NO2 | IQR | 29% (5, 58) | |||||
6 | Seo, et al. (2007)33 | Cohort | 2002–2003 | Seoul | Low birth weight | CO | IQR | RR 1.081 (1.002, 1.166) |
Low birth weight | SO2 | IQR | RR 1.145 (1.036, 1.267) | |||||
Low birth weight | PM10 | IQR | RR 1.053 (1.002, 1.108) | |||||
Low birth weight | NO2 | IQR | RR 1.003 (0.954, 1.055) | |||||
7 | Moon, et al. (2009)74 | 4 cities | Respiratory symptoms | 5 criteria pollutants | Significant positive association with SO2 and NO2 | |||
8 | Seo, et al. (2010)34 | Cohort | 2004 | Seoul | Low birth weight | PM10 | OR 1.08 (0.99, 1.18) | |
Busan | Low birth weight | PM10 | OR 1.24 (1.02, 1.52) | |||||
Daegu | Low birth weight | PM10 | OR 1.19 (1.04, 1.37) | |||||
Incheon | Low birth weight | PM10 | OR 1.12 (0.98, 1.28) | |||||
Gwangju | Low birth weight | PM10 | OR 1.22 (0.98, 1.52) | |||||
Daejeon | Low birth weight | PM10 | OR 1.06 (1.00, 1.11) | |||||
Ulsan | Low birth weight | PM10 | OR 1.19 (1.03, 1.38) | |||||
9 | Yi, et al. (2010)75* | Case-crossover | 2001–2006 | Cardiovascular hospitalization | PM10 | 10 μg/m3 | 0.77% (0.53, 1.01) | |
Respiratory hospitalization | PM10 | 10 μg/m3 | 1.19% (0.94, 1.44) | |||||
10 | Kim, et al. (2011)26 | Cohort | 12-month prevalence of wheeze | O3 | 5 ppb | OR 1.372 (1.016, 1.852) | ||
11 | Lim, et al. (2012)31 | Panel study | Seoul | Depression (SGDS-K) | PM10 | IQR | 17.0% (4.9, 30.5) | |
Depression (SGDS-K) | NO2 | IQR | 32.8% (12.6, 65.6) | |||||
Depression (SGDS-K) | O3 | IQR | 43.7% (11.5, 85.2) | |||||
12 | Kim, et al. (2012)76 | Panel study | Seoul | Insulin resistance | PM10, O3, NO2 | IQR | Significantly increased | |
13 | Kim, et al. (2013)77 | Cross sectional | Allergic diseases | Traffic related pollutants | Polluted vs. non-polluted school | OR 2.12 (1.41, 3.19) | ||
14 | Kim, et al. (2013)27 | Cohort | Airway hyperresponsiveness | O3 | OR 1.60 (1.13, 2.27) | |||
New episodes of wheezing | O3 | OR 1.92 (0.96, 3.83) | ||||||
15 | Han, et al. (2013)78 | Hemorrhagic fever with renal syndrome | PM10 | 1 μg/m3 | 0.013 increase of monthly cases | |||
16 | Son, et al. (2013)79 | 2003–2008 | 8 cities | Allergic disease hospital admission | PM10 | IQR (30.7 μg/m3) | 2.2% (0.5, 3.9) | |
Asthma hospital admission | PM10 | IQR (30.7 μg/m3) | 2.8% (1.3, 4.4) | |||||
Respiratory hospital admission | PM10 | IQR (30.7 μg/m3) | 1.7% (0.9, 2.6) | |||||
Cardiovascular hospital admission | PM10 | IQR (30.7 μg/m3) | ||||||
Allergic disease hospital admission | NO2 | IQR (12.2 ppb) | 2.3% (0.6, 4.0) | |||||
Asthma hospital admission | NO2 | IQR (12.2 ppb) | 2.2% (0.3, 4.1) | |||||
Respiratory hospital admission | NO2 | IQR (12.2 ppb) | 2.2% (0.6, 3.7) | |||||
Cardiovascular hospital admission | NO2 | IQR (12.2 ppb) | 2.2% (1.1, 3.4) | |||||
17 | Park, et al. (2013)80 | Time series | 7 cities | Asthma admission | PM10, CO, O3, NO2 | Children vs. adult | Lower risk in children for PM10 and CO | |
18 | Kim, et al. (2014)81 | Cohort | Neurodevelopment (MDI) | PM10 | β=-2.83; p=0.003 | |||
19 | Hwang, et al. (2014)82 | Retrospective cohort | Seoul | Neurodevelopment (PDI) | PM10 | β=-3.00; p=0.002 | ||
20 | Han, et al. (2015)28 | Time series | 2004–2013 | Tuberculosis | SO2 | IQR | RR 1.07 (1.03, 1.12) | |
21 | Kim, et al. (2015)83 | Case-crossover | Korea | Hourly asthma ED visit | PM10-2.5 | IQR | OR 1.05 (1.00, 1.11) | |
Hourly asthma ED visit | O3 | IQR | OR 1.10 (1.04, 1.16) | |||||
22 | Jang, et al. (2015)84 | Ecological | Korea | Monthly malaria incidence | NO2 | β=-0.884, p<0.01 | ||
23 | Shim, et al. (2016)85 | Cross sectional | 2010–2013 | Korea | Benign prostate hyperplasia | NO2 | OR 2.23 (1.55, 2.39) | |
Benign prostate hyperplasia | SO2 | OR 2.02 (1.42, 2.88) | ||||||
24 | Kang, et al. (2016)86 | Time series | 2006–2013 | Seoul | Cardiac arrest | PM2.5 | 10 μg/m3 | 1.30% (0.20, 2.41) |
25 | Kim, et al. (2016)87 | Cross sectional | Allergic rhinitis | CO (during the first year of life) | 100 ppb | OR 1.10 (1.03, 1.19) | ||
Atopic dermatitis | CO (past 12 months) | 1 ppm | OR 8.11 (1.06, 62.12) | |||||
26 | Kim, et al. (2016)88 | Cross sectional | Asthma | NO2 | OR 1.67 (1.03, 2.71) | |||
Allergic rhinitis | Black carbon | OR 1.60 (1.36, 1.90) | ||||||
Allergic rhinitis | SO2 | OR 1.09 (1.01, 1.17) | ||||||
Allergic rhinitis | NO2 | OR 1.18 (1.07, 1.30) | ||||||
27 | Han, et al. (2016)89 | Time series | 2004–2014 | Seongdong-gu, Seoul | Intracerebral hemorrhage | PM10 | RR | 1.09 (1.02, 1.15) |
Subarachnoid hemorrhage | O3 | RR | 1.32 (1.10, 1.58) | |||||
28 | Kim, et al. (2016)32 | Cohort | 2002–2010 | Korea | Major depressive disorder | PM2.5 | 10 μg/m3 | HR 1.44 (1.17-1.78) |
29 | Lee, et al. (2016)90 | Cross sectional | 2008–2010 | Korea | Hypertension | PM10 | 10 μg/m3 | OR 1.042 (1.009, 1.077) |
Hypertension in >30 years old | PM10 | 10 μg/m3 | OR 1.044 (1.009, 1.079) | |||||
Stroke | PM10 | 10 μg/m3 | OR 1.044 (0.979, 1.114) | |||||
Angina | PM10 | 10 μg/m3 | OR 0.977 (0.901, 1.059) | |||||
Hypertension | NO2 | 10 ppb | OR 1.077 (1.044, 1.112) | |||||
Hypertension | in >30 years old NO2 | 10 ppb | OR 1.080 (1.043, 1.118) | |||||
Stroke | NO2 | 10 ppb | OR 1.073 (0.994, 1.157) | |||||
Angina | NO2 | 10 ppb | OR 1.047 (0.968, 1.134) | |||||
Hypertension | CO | 10 ppb | OR 1.123 (0.963, 1.310) | |||||
Hypertension in >30 years old | CO | 10 ppb | OR 1.129 (0.963, 1.387) | |||||
Stroke | CO | 10 ppb | OR 1.336 (0.987, 2.011) | |||||
30 | Lee, et al. (2017)91 | Cross sectional | 2008–2011 | Korea | Pterygium | PM10 | 5 μg/m3 | OR 1.23 p=0.023 |
31 | Chung, et al. (2017)92 | Cardioembolic stroke | PM10 | Significantly increased | ||||
Cardioembolic stroke | SO2 | Significantly increased | ||||||
32 | Kim, et al. (2016)93 | Randomized intervention trial | Atopic dermatitis | Indoor VOC | Environmentally friendly vs. PVC wallpaper | More improvement in environmentally friendly wallpaper group | ||
33 | Ha, et al. (2017)29 | Ecological | 1999–2008 | Male lung cancer | Indoor radon | 10 Bq/m3 | 0.01 | |
Female children non-Hodgkin's lymphoma | Indoor radon | 10 Bq/m3 | 0.07 | |||||
34 | Hwang, et al. (2017)94 | Time series | Cardiovascular ED visit | NH4+ (PM2.5 component) | RR 1.05 (1.01, 1.09) | |||
35 | Kim, et al. (2017)18* | Cohort | 2007–2013 | Seoul | Acute myocardial infarction | PM2.5 | 1 μg/m3 | 1.36 (1.19, 1.56) |
Congestive heart failure | PM2.5 | 1 μg/m3 | 1.44 (1.29, 1.61) | |||||
Stroke | PM2.5 | 1 μg/m3 | 1.39 (1.27, 1.52) | |||||
Acute myocardial infarction | CO | IQR (0.25 ppm) | 2.12 (1.72, 2.61) | |||||
Congestive heart failure | CO | IQR (0.25 ppm) | 1.86 (1.56, 2.21) | |||||
Stroke | CO | IQR (0.25 ppm) | 2.00 (1.73, 2.30) | |||||
Acute myocardial infarction | SO2 | IQR (2.54 ppb) | 1.82 (1.52, 2.19) | |||||
Congestive heart failure | SO2 | IQR (2.54 ppb) | 2.00 (1.73, 2.32) | |||||
Stroke | SO2 | IQR (2.54 ppb) | 2.25 (2.00, 2.54) | |||||
Acute myocardial infarction | NO2 | IQR (18.4 ppb) | 1.81 (1.46, 2.25) | |||||
Congestive heart failure | NO2 | IQR (18.4 ppb) | 2.40 (2.02, 2.85) | |||||
Stroke | NO2 | IQR (18.4 ppb) | 2.65 (2.29, 3.06) | |||||
Acute myocardial infarction | O3 | IQR (15.9 ppb) | 0.71 (0.63, 0.82) | |||||
Congestive heart failure | O3 | IQR (15.9 ppb) | 0.64 (0.58, 0.71) | |||||
Stroke | O3 | IQR (15.9 ppb) | 0.60 (0.55, 0.65) | |||||
36 | Lamichhane, et al. (2017)30 | Case-control | Korea | Lung cancer | PM10 | 10 μg/m3 | OR 1.09 (0.96, 1.23) | |
NO2 | 10 ppb | OR 1.10 (1.00, 1.22) | ||||||
37 | Yi, et al. (2017)95 | Cross sectional | 2010 | Seoul | Children's atopic eczema | Road density | OR 1.08 (1.01, 1.15) | |
Road proximity | OR 1.15 (1.01, 1.31) | |||||||
38 | Lamichhane, et al. (2018)96 | Birth cohort | Fetal growth (BPD) | PM10 | 10 μg/m3 | -0.26 mm (-0.41, -0.11) | ||
NO2 | 10 μg/m3 | -0.30 mm (-0.59, -0.03) |
SES, socioeconomic status; SGDS-K, Short Geriatric Depression Scale-Korean; MDI, mental developmental index; PDI, psychomotor developmental index; BPD, biparietal diameter; VOC, volatile organic carbon; PVC: polyvinyl chloride; IQR, interquartile range; OR, odds ratio; RR, relative risk; HR, hazard ratio; 7 cities, Seoul, Incheon, Daejeon, Gwangju, Daegu, Busan, Ulsan.
*From the search results of mortality studies.
Table 3
No. | Autor (year) | Study period | Location | Outcome | Pollutant | Health impact (person) |
---|---|---|---|---|---|---|
1 | Leem, et al. (2015)37 | 2010 | Seoul metropolitan area | Attributable number of deaths | PM2.5 | 15346 |
Attributable number of respiratory hospital admission | PM10 | 12511 | ||||
Attributable number of cardiovascular hospital admission | PM10 | 12351 | ||||
Attributable number of lung cancer incidence | PM10 | 1403 | ||||
Attributable number of asthma attack (children) | PM10 | 11389 | ||||
Attributable number of asthma attack (adults) | PM10 | 44006 | ||||
Attributable number of chronic bronchitis | PM10 | 20490 | ||||
Attributable number of acute bronchitis | PM10 | 278346 | ||||
2 | Yorifuji, et al. (2015)35 | 2009 | Seoul | Attributable number of deaths | PM10 over 20 μg/m3 | 5840 |
Busan | Attributable number of deaths | PM10 over 20 μg/m3 | 2465 | |||
Daegu | Attributable number of deaths | PM10 over 20 μg/m3 | 1466 | |||
Incheon | Attributable number of deaths | PM10 over 20 μg/m3 | 1931 | |||
Daejeon | Attributable number of deaths | PM10 over 20 μg/m3 | 599 | |||
Gwangju | Attributable number of deaths | PM10 over 20 μg/m3 | 698 | |||
Ulsan | Attributable number of deaths | PM10 over 20 μg/m3 | 539 | |||
3 | Yoon, et al. (2015)38 | 2007 | Korea | Disability-adjusted life years | Out door air pollution | 6.89/1000 person |
4 | Han, et al. (2018)36 | Korea | Attributable number of deaths | PM2.5 | 11924 | |
Seoul | Attributable number of deaths | PM2.5 | 1763 | |||
Busan | Attributable number of deaths | PM2.5 | 947 | |||
Daegu | Attributable number of deaths | PM2.5 | 672 | |||
Incheon | Attributable number of deaths | PM2.5 | 309 | |||
Gwangju | Attributable number of deaths | PM2.5 | 657 | |||
Daejeon | Attributable number of deaths | PM2.5 | 342 | |||
Ulsan | Attributable number of deaths | PM2.5 | 222 | |||
Sejong | Attributable number of deaths | PM2.5 | 49 |